Nina Singh Selected Research

Transplantation (Transplant Recipients)

09/2008	Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens.
12/2007	Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients.
10/2007	Alternaria alternata Soft Tissue Infection in a Forearm Transplant Recipient.
06/2007	Inching closer towards optimization of treatment for latent tuberculosis in liver transplant recipients.
05/2007	Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
12/2006	Human herpesvirus-6 infection in solid organ and stem cell transplant recipients.
02/2006	Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients.
10/2005	Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome.
05/2005	Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.
01/2005	Aspergillus infections in transplant recipients.
01/2005	Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
07/2004	Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.
05/2004	Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.
01/2004	Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients.
01/2004	Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients.
06/2003	Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
03/2003	Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients.
01/2003	Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
01/2003	Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.
11/2002	The changing face of invasive aspergillosis in liver transplant recipients.
04/2002	Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.
03/2002	Nocardia infection in lung transplant recipients.
01/2002	Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.

Articles by Research Topic

Disease

21	Infection 10/2008 - 01/2002
8	Aspergillosis 03/2008 - 11/2002
3	Cryptococcosis 09/2008 - 01/2008
3	Bacteremia 12/2007 - 10/2002
2	Tuberculosis 06/2007 - 09/2002
2	Opportunistic Infections (Opportunistic Infection) 10/2006 - 05/2005
2	Cytomegalovirus Infections (Inclusion Disease) 04/2006 - 01/2004
2	Immune Reconstitution Inflammatory Syndrome 10/2005 - 06/2005
1	Iron Overload 09/2008
1	Zygomycosis (Phycomycosis) 06/2008
1	Soft Tissue Infections 10/2007
1	Hypercalcemia (Milk Alkali Syndrome) 10/2006
1	Fibrosis (Cirrhosis) 05/2004
1	Mycoses (Diseases, Fungus) 03/2004
1	Candidiasis (Moniliasis) 06/2003
1	Bronchiolitis Obliterans 12/2002
1	Hemorrhage 07/2002
1	Hepatitis 04/2002
1	Nocardia Infections 03/2002

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2008 - 01/2004
3	galactomannanIBA 05/2007 - 01/2004
2	Immunosuppressive Agents (Immunosuppressants)IBA 03/2004 - 07/2002
1	Antifungal AgentsIBA 02/2008
1	CalcineurinIBA 02/2008
1	IronIBA 12/2007
1	voriconazole (Vfend)FDA Link 02/2006
1	caspofungin (Cancidas)FDA Link 02/2006
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2003
1	Isoniazid (Ftivazide)FDA LinkGeneric 09/2002

Therapy/Procedure

23	Transplants (Transplant) 10/2008 - 07/2002
23	Transplantation (Transplant Recipients) 09/2008 - 01/2002
3	Lung Transplantation 03/2003 - 12/2002
1	Drug Therapy (Chemotherapy) 10/2008
1	Homologous Transplantation (Allograft) 10/2005
1	Organ Transplantation 03/2003
1	Chemoprevention 09/2002
1	Intensive Care (Surgical Intensive Care) 09/2002
1	Liver Transplantation 07/2002